[Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
In eleven volunteers and 39 patients undergoing transurethral resection of the prostate or bladder tumor, concentrations of enoxacin were measured in seminal fluid (volunteers), in prostatic fluid (volunteers, patients) and in prostatic adenoma tissue (patients) after oral (400 mg) administration and intravenous (428 mg) infusion (60 min) of enoxacin. Simultaneously 2.534 g of iothalamic acid was i.v. injected to identify possible urinary contamination. The concentrations of enoxacin in seminal fluid after 2-4 h and in prostatic tissue after about 1-4 h and 14-16 h exceeded plasma concentrations more than two-fold. The concentrations in prostatic fluid after 1-4 h were about half the plasma concentrations. Venous blood samples were taken after intravenous infusion at intervals of up to 24 h in a total of 14 patients. The mean plasma concentration of enoxacin decreased from its maximum of 6.9 mg/l at the end of infusion to 0.5 mg/l at 12 h after administration. A terminal half life of 6.65 h was calculated according to an open two-compartment model.
Naber
K G
KG
Urologische Klinik, Elisabeth Krankenhaus, Straubing.
Sörgel
F
F
Kees
F
F
Schumacher
H
H
Sigl
G
G
Zürcher
J
J
Berger
S
S
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001826:Body Fluids / Q000032:analysis*; D015365:Enoxacin / Q000008:administration & dosage / Q000032:analysis*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000032:analysis / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000378:metabolism*; D012661:Semen / Q000032:analysis*
D015365:Enoxacin
Enoxacin-Konzentrationen in der Samenflüssigkeit, im Prostatasekret und im Prostataadenomgewebe nach oraler Gabe oder intravenöser Infusion.